Stock Events

Stock Events

Sanofi 

$45.78
5333
+$0.08+0.18% 08:39 Today

Statistics

Day High
46.22
Day Low
45.2
52W High
46.22
52W Low
39.27
Volume
2,474
Avg. Volume
-
Mkt Cap
109.7B
P/E Ratio
-
Dividend Yield
5.28%
Dividend
2.42

Upcoming

Dividends

5.28%Dividend Yield
Jun 2026
$2.42
Jun 2025
$2.20
Jun 2024
$2.04
Jun 2023
$1.90
Jun 2022
$0.18
10Y Growth
3.82%
5Y Growth
4.63%
3Y Growth
8.38%
1Y Growth
10.19%

Earnings

Jul 30Expected
Q2 2025
Q4 2025
Q2 2026
999
333
-333
-999
Expected EPS
N/A
Actual EPS
N/A

Financials

17.19%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
52.44BRevenue
9.02BNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SNY.BOATS. It's not an investment recommendation.
TotalEnergies
1555
TTE.PA
Air Liquide
1230
AI.PA
Axa
1043
CS.PA
Lvmh Moet Hennessy Louis Vuitton
882
MC.PA

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer competes directly with Sanofi in various therapeutic areas, including vaccines and oncology.
Merck
MRK
Mkt Cap368.89B
Merck is a key competitor in the pharmaceutical sector, especially in vaccines and immunology, areas where Sanofi also operates.
Novartis
NVS
Mkt Cap303.67B
Novartis competes with Sanofi in multiple segments including generics through Sandoz, and in innovative prescription drugs.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson competes across a broad range of healthcare products, including pharmaceuticals in areas overlapping with Sanofi's portfolio.
GSK
GSK
Mkt Cap99.19B
GlaxoSmithKline is a competitor in the vaccines and respiratory diseases market, directly competing with Sanofi.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie competes in the immunology and oncology sectors, directly challenging Sanofi's offerings.
Roche
RHHBY
Mkt Cap334.28B
Roche, through its pharmaceutical division, competes in the oncology and immunology markets, areas where Sanofi is also a key player.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca competes with Sanofi in areas such as oncology, cardiovascular diseases, and respiratory diseases.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb competes in the oncology, cardiovascular, and immunoscience fields, overlapping with Sanofi's interests.
AMGEN
AMGN
Mkt Cap251.94B
Amgen competes in the biopharmaceutical sector focusing on treatments in areas like oncology and osteoporosis, where Sanofi also has a presence.

About

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Show More
CEO
ISIN
US80105N1054

Listings

MX
MX
SAN1N.MX
OTC Link
US
SNYNF
STU
DE
SNW2.STU
F
DE
SNW1.F

0 Comments

Share your thoughts

FAQs

What is Sanofi stock price today?▼
The current price of SNY.BOATS is $45.78 USD — it has increased by +0.18% in the past 24 hours. Watch Sanofi stock price performance more closely on the chart.
What is Sanofi stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Sanofi stocks are traded under the ticker SNY.BOATS.
What is Sanofi market cap?▼
Today Sanofi has the market capitalization of 109.7B
What is Sanofi revenue for the last year?▼
Sanofi revenue for the last year amounts to 52.44B USD.
What is Sanofi net income for the last year?▼
SNY.BOATS net income for the last year is 9.02B USD.
Does Sanofi pay dividends?▼
Yes, SNY.BOATS dividends are paid annual. The last dividend per share was 2.42 . As of today, Dividend Yield (FWD)% is 5.28%.
In which sector is Sanofi located?▼
Sanofi operates in the Other sector.
When did Sanofi complete a stock split?▼
Sanofi has not had any recent stock splits.